Additional file 3: of Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial

Table S1. Biological safety and biological activity analysis of the clinical-grade cells$ recognized by the National Institutes for Food and Drug Control (NIFDC). $: This table is translated from NIFDC report numbers, SH20140138 for UC-MSC. (DOCX 21 kb)